Skip to content
initiative Octalfa
Engagés pour l'innovation et la santé
initiative Octalfa
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • fr
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • fr

Yearly Archives: 2019

You are here:
  1. Home
  2. 2019

Orphelia Pharma

ORPHELIA Pharma announces Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma

UncategorizedBy Charlotte Maddalena10 December 2019

Newsletter november 2019

UncategorizedBy Charlotte Maddalena4 December 2019

It has been a busy year for our Endowment Fund and Corporate Foundation!

Fondation

Two new projects supported by our Foundation

UncategorizedBy Charlotte Maddalena4 December 2019

The 22th of november 2019, the board of directors of the Foundation Dominique & Tom Alberici decided to support “APPEL” and “le Gai-Rire”,

Orphelia Pharma

ORPHELIA Pharma announces the granting of the Marketing Authorisation for Ivozall® from the European Commission

UncategorizedBy Charlotte Maddalena25 November 2019

Preclinical data of novel ICI combination with anti-PD1 or anti-CTLA4 therapies

UncategorizedBy Charlotte Maddalena7 November 2019

Orphelia Pharma

ORPHELIA Pharma and Veriton Pharma execute a license and distribution agreement for Kigabeq® in the United Kingdom

UncategorizedBy Charlotte Maddalena28 October 2019

Orphelia Pharma

ORPHELIA announces the appointment of Dr. Caroline Lemarchand as Chief Pharmaceutical Development Officer

UncategorizedBy Charlotte Maddalena15 October 2019

First-in-class immune checkpoint inhibitor to be presented at SITC

UncategorizedBy Charlotte Maddalena1 October 2019

Orphelia Pharma

ORPHELIA announces that the CHMP has adopted a positive opinion for Ivozall®

UncategorizedBy Charlotte Maddalena1 October 2019

Ivozall® is an essential medicine intended for the treatment of relapsed or refractory Acute Lymphoblastic Leukaemia in children

Baikowski® hereby confirms its acquisition of Mathym SAS, a company with which it commenced negotiations in July 2019

UncategorizedBy Charlotte Maddalena1 October 2019
123
Go to Top